Delaying measles jab raises risk of seizure; Vivaldi buys Baxter flu vaccine assets;

> Delaying a newborn's measles vaccination could increase risk of seizures, researchers report. Study

> Vivaldi Biosciences has bought flu vaccine assets from Baxter Healthcare ($BAX). Release (PDF)

> Cel-Sci and CRO Ergomed have signed a co-development deal for immunotherapy drug Multikine. Item

> Germany's immatics has raised $46 million for a Phase III trial of its cancer vaccine. News

> Taiwan expects to have an H7N9 vaccine by late next year. Article

> CSL is to buy back almost AU$1 billion of shares over the next 12 months. Piece

Suggested Articles

CEPI, which started to help prepare the world for new outbreaks, has awarded Inovio and Moderna money for vaccine work against the new coronavirus.

As a new coronavirus spreads, vaccine researchers have started work on candidates against the virus—and one could enter the clinic in a few months.

Merck's HPV vaccine Gardasil is delivering blockbuster sales as demand surges. But high demand has caused somewhat of a supply constraint.